Musculoskeletal conditions represent one of the most substantial financial and operational burdens placed upon global healthcare systems and national economies. In the United Kingdom alone, over 20 million people suffer from an MSK condition, generating between 18% and 30% of all general practitioner (GP) consultations and costing the National Health Service (NHS) approximately £5 billion annually.

Flok Health’s oversubscribed $12.5M Series A round highlights a broader maturation of autonomous clinical AI in regulated medical environments. By securing CQC registration to autonomously diagnose, treat and discharge patients, Flok Health has established a new precedent for digital clinical practice in a single-payer healthcare system.